Search results
Diabetic ketoacidosis (DKA) is a frequent and potentially life-threatening complication of type 1 diabetes. Though preventable and despite advances in monitoring technologies, insulin therapeutics and insulin delivery systems, the rates of both community and hospital acquired DKA remain largely unchanged. Although mortality today is relatively
22 maj 2020 · This is a subcutaneous (SubQ) insulin protocol that replaces insulin drip needs for mild to moderate DKA. Procedures are adapted for COVID-related considerations of minimizing risk to staff while optimizing patient safety and health.
IV Regular Insulin Infusion. B. Start at DKA START Instructions Tab. Follow prompts for K replacement and IV Regular Insulin drip. D. Once K and Magnesium are within acceptable range, proceed to Step 2. E. If there is no insulin infusion, discuss with provider to consider low dose infusion and initiate. Is K less than 3.3? aintenance IV ...
Add Dextrose (D51⁄2NS or D5NS*) to IVF @ 150 – 250 mL/h to maintain serum glucose 150 – 200 mg/dL and continue insulin at same rate. Titrate insulin to a minimum 0.1 Units/kg/hr and glucose goal between 150 – 200 mg/dL until ketosis and anion gap resolves.
intravenous insulin, cbg and ketones monitoring record sheet Guide: Only use for patients on intravenous insulin regimen (use different chart for patients on subcutaneous insulin)
Diabetic Ketoacidosis (DKA) Two Bag System Protocol [3361] DKA: Blood glucose greater than 250 mg/dL, arterial or venous pH less than 7.3, serum bicarbonate less than 15 mEq/L anion gap greater than 12 and ketonuria or ketonemia. Discontinue all previous insulin orders and oral diabetes medications.
This is a subcutaneous (SC) insulin protocol that replaces the IV insulin infusion needs for mild to moderate DKA, adapted to minimize the risks to staff exposure, use of PPE, while optimizing patient safety. When patient’s DKA resolves, this protocol will be discontinued.
